TCL Healthcare Equipment to Acquire the Majority Share of Eckert & Ziegler BEBIG’s HDR Brachytherapy Business

author: Time:2020.09.18 18:55:40 Click:504

TCL Healthcare Equipment (Shanghai) Co., Ltd. (TCL Healthcare Equipment) and Eckert & Ziegler BEBIG GmbH (Eckert & Ziegler BEBIG) have entered into an agreement, pursuant to which Eckert & Ziegler BEBIG shall carve out its high dose rate (HDR) brachytherapy business into a new subsidiary (“NewCo.”)  and TCL Healthcare Equipment shall acquire the majority shares of this new subsidiary while Eckert & Ziegler BEBIG remains as a significant shareholder. The production of the tumor irradiation devices shall remain in Germany.


This is another significant movement for both companies after they formed a joint venture for HDR Brachytherapy business in China in 2019. This new movement will create an even stronger healthcare market leader for HDR brachytherapy by combining the strengths and resources of both parties.


Mr. George Chan, Chairman of TCL Healthcare Equipment said, “Eckert & Ziegler BEBIG, which is outstandingly reputable in the industry with its innovative technologies and reliable qualities, is the ideal partner for us. The NewCo. is expected to inherit the essences of the reputable brand, cutting-edge technologies, reliable manufacturing qualities from Eckert & Ziegler BEBIG as well as the comprehensive go-to-market resources and networks from TCL Healthcare Equipment. This is a transformational step for us to enter into the attractive growing radiation therapy arena and is perfectly aligned with our vision --- affordable healthcare for everyone.”


Dr. Harald Hasselmann, Member of the Executive Board of Eckert & Ziegler AG and Managing Director of Eckert & Ziegler BEBIG said, "TCL is the right partner for our business with tumor radiation equipment. TCL shares both our strategy and our values and is therefore the best choice to drive the growth of our HDR business worldwide". With TCL we already run a joint venture for the Chinese market since 2019. This cooperation is now being expanded to strengthen our worldwide commercialization of HDR devices.


The transaction is expected to be closed by the end of 2020 and the NewCo. is expected to start operation from January 1st, 2021.


Media Contact

TCL Healthcare Equipment:

Contact person: Crystal Chen, Operation Director




Eckert & Ziegler BEBIG:

Contact person: Karolin Riehle, Public Relations